Glycemic Control and Obesity Among People With Type 2 Diabetes in Europe and Australia: A Retrospective Cohort Analysis.
Cohort study
Database research
Glycemic control
Observational study
Type 2 diabetes
Journal
Diabetes therapy : research, treatment and education of diabetes and related disorders
ISSN: 1869-6953
Titre abrégé: Diabetes Ther
Pays: United States
ID NLM: 101539025
Informations de publication
Date de publication:
29 Apr 2024
29 Apr 2024
Historique:
received:
19
12
2023
accepted:
04
04
2024
medline:
29
4
2024
pubmed:
29
4
2024
entrez:
29
4
2024
Statut:
aheadofprint
Résumé
In people with type 2 diabetes (PwT2D) who also have obesity, efforts targeting weight loss, including lifestyle, medication and surgical interventions, are recommended. The objective of this study was to explore the relationship between glycemic control and obesity among PwT2D in Europe and Australia using recent real-world data and applying consistent methodology across countries. Retrospective study utilizing IQVIA electronic medical records (EMR) databases grouped into panels based on specialty of contributing physicians. General practitioner (GP) and endocrinologist/diabetologist (E/D) panels were used in Germany and France, while GP panels were used in Italy, UK and Australia. The Spanish database included all physician specialties. The sample included PwT2D with glycated hemoglobin A1c (HbA1c) and body mass index (BMI) values measured within 90 days of each other between January 2015 and December 2018 (second record termed the 'index date'). PwT2D had a 1-year baseline period and a recorded HbA1c at the end of the 1-year post-index period. The final sample comprised 194,729 PwT2D. At baseline, across countries/panels, 36.8-58.0% were above HbA1c target (HbA1c ≥ 7%) and 39.4-56.7% had obesity (BMI ≥ 30.0 kg/m This study presents data on HbA1c and BMI among type 2 diabetes (T2D) populations in Europe and Australia. A notable proportion of PwT2D had obesity and were above HBA1c target. Higher BMI was associated with poorer glycemic control.
Identifiants
pubmed: 38683494
doi: 10.1007/s13300-024-01583-w
pii: 10.1007/s13300-024-01583-w
doi:
Types de publication
Journal Article
Langues
eng
Informations de copyright
© 2024. The Author(s).
Références
International Diabetes Federation. Diabetes facts & figures 2021. Available from: https://www.idf.org/aboutdiabetes/what-is-diabetes/facts-figures.html .
International Diabetes Federation. Type 2 diabetes 2020. Available from: https://www.idf.org/aboutdiabetes/type-2-diabetes.html .
Lingvay I, Sumithran P, Cohen RV, le Roux CW. Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation. Lancet. 2022;399(10322):394–405.
doi: 10.1016/S0140-6736(21)01919-X
pubmed: 34600604
Grant B, Sandelson M, Agyemang-Prempeh B, Zalin A. Managing obesity in people with type 2 diabetes. Clin Med (Lond). 2021;21(4):e327–e231.
doi: 10.7861/clinmed.2021-0370
pubmed: 35192472
Davies MJ, Dalessio DA, Fradkin J, et al. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2018;41(12):2669–701.
American Diabetes Association. 8. Obesity management for the treatment of type 2 diabetes: standards of medical care in diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S100-s110.
doi: 10.2337/dc21-S008
Wing RR, Lang W, Wadden TA, et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care. 2011;34(7):1481–6.
doi: 10.2337/dc10-2415
pubmed: 21593294
pmcid: 3120182
Rubin RR, Wadden TA, Bahnson JL, et al. Impact of intensive lifestyle intervention on depression and health-related quality of life in type 2 diabetes: the Look AHEAD Trial. Diabetes Care. 2014;37(6):1544–53.
doi: 10.2337/dc13-1928
pubmed: 24855155
American Diabetes Association Professional Practice Committee. 6. Glycemic targets: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S83–96.
doi: 10.2337/dc22-S006
Boye KS, Lage MJ, Shinde S, Thieu V, Bae JP. Trends in HbA1c and body mass index among individuals with type 2 diabetes: evidence from a US database 2012–2019. Diabetes Ther. 2021;12(7):2077–87.
doi: 10.1007/s13300-021-01084-0
pubmed: 34076849
pmcid: 8266935
Boye KS, Lage MJ, Thieu V, Shinde S, Dhamija S, Bae JP. Obesity and glycemic control among people with type 2 diabetes in the United States: a retrospective cohort study using insurance claims data. J Diabetes Complication. 2021;35(9): 107975.
doi: 10.1016/j.jdiacomp.2021.107975
Kennedy-Martin T, Boye KS, Kennedy-Martin M. The Association between body mass index and glycemic control in patients with type 2 diabetes across eight countries: a literature review. Curr Res Diabetes Obes J. 2021. https://doi.org/10.19080/CRDOJ.2021.15.555904 .
doi: 10.19080/CRDOJ.2021.15.555904
Launay T, Souty C, Vilcu AM, et al. Common communicable diseases in the general population in France during the COVID-19 pandemic. PLoS One. 2021;16(10): e0258391.
doi: 10.1371/journal.pone.0258391
pubmed: 34634090
pmcid: 8504745
Jouaville SL, Miotti H, Coffin G, Sarfati B, Meihoc A. Validity and limitations of the longitudinal patient database france for use in pharmacoepidemiological and pharmacoeconomics studies. Value Health. 2015;18:1–307.
doi: 10.1016/j.jval.2015.03.115
Rathmann W, Bongaerts B, Carius HJ, Kruppert S, Kostev K. Basic characteristics and representativeness of the German Disease Analyzer database. Int J Clin Pharmacol Ther. 2018;56(10):459–66.
doi: 10.5414/CP203320
pubmed: 30168417
Istituto di ricerca della SIMG. XIV report Health Search. 2021: Società Italiana di Medicina Generale e delle Cure Primarie; 2021. Available from: https://report.healthsearch.it/XV_REPORT_HS.pdf .
Almonacid C, Fitas E, Sánchez-Covisa J, Gutiérrez H, Rebollo P. Geographical differences in the use of oral corticosteroids in patients with severe asthma in Spain: heat map based on existing databases analyses. BMC Pulm Med. 2023;23(1):3.
doi: 10.1186/s12890-022-02295-2
pubmed: 36600236
pmcid: 9812540
Blak BT, Thompson M, Dattani H, Bourke A. Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates. Inform Prim Care. 2011;19(4):251–5.
pubmed: 22828580
Glasheen WP, Renda A, Dong Y. Diabetes Complications Severity Index (DCSI)—update and ICD-10 translation. J Diabetes Complications. 2017;31(6):1007–13.
doi: 10.1016/j.jdiacomp.2017.02.018
pubmed: 28416120
OECD, European Union. Diabetes prevalence 2020. Available from: https://www.oecd-ilibrary.org/content/component/83231356-en .
Australian Bureau of Statistics (ABS), 2020–21. Diabetes. Available from: https://www.abs.gov.au/statistics/health/health-conditions-and-risks/diabetes/latest-release .
Davies MJ, Aroda VR, Collins BS, et al. Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2022;45(11):2753–86.
doi: 10.2337/dci22-0034
pubmed: 36148880
pmcid: 10008140
Awa WL, Fach E, Krakow D, et al. Type 2 diabetes from pediatric to geriatric age: analysis of gender and obesity among 120183 patients from the German/Austrian DPV database. Eur J Endocrinol. 2012;167(2):245.
doi: 10.1530/EJE-12-0143
pubmed: 22645200
Salinero-Fort MA, San Andrés-Rebollo FJ, Gómez-Campelo P, et al. MADIABETES Research Group. Body mass index and all-cause mortality among type 2 diabetes mellitus patients: findings from the 5-year follow-up of the MADIABETES cohort. Eur J Intern Med. 2017;43:46–52.
doi: 10.1016/j.ejim.2017.06.021
pubmed: 28679485
Aucott LS, Philip S, Avenell A, et al. Patterns of weight change after the diagnosis of type 2 diabetes in Scotland and their relationship with glycaemic control, mortality and cardiovascular outcomes: a retrospective cohort study. BMJ Open. 2016;6(7): e010836.
doi: 10.1136/bmjopen-2015-010836
pubmed: 27466237
pmcid: 4964186
Hovestadt I, Kiess W, Lewien C, et al. HbA1c percentiles and the association between BMI, age, gender, puberty, and HbA1c levels in healthy German children and adolescents. Pediatr Diabetes. 2022;23(2):194–202.
doi: 10.1111/pedi.13297
pubmed: 34877761
Mukherjee J, Sternhufvud C, Smith N, et al. Association between weight change, clinical outcomes, and health care costs in patients with type 2 diabetes. J Manag Care Spec Pharm. 2016;22(5):449–66.
pubmed: 27123909
Slåtsve KB, Claudi T, Lappegård KT, et al. Factors associated with treatment in primary versus specialist care: a population-based study of people with type 2 and type 1 diabetes. Diabet Med. 2021;38(7): e14580.
doi: 10.1111/dme.14580
pubmed: 33834523
Kanavos P, Aardweg S, Schurer W. Diabetes expenditure, burden of disease and management in 5 EU countries. 2012.